Strengthening its commitment to education and research, Prodia re-establishes strategic collaboration with the Faculty of Medicine, Tadulako University.
21 Jun 2026
PT Prodia Widyahusada Tbk (stock code: PRDA) has extended its collaboration with the Faculty of Medicine, Tadulako University (FK Tadulako) in the field of clinical laboratory education and research.
The signing of this collaboration was carried out on June 22, 2026 by Dr. Indriyanti Rafi Sukmawati, M.Si as Commercial & Partnership Director of PT Prodia Widyahusada Tbk and Dr. dr. M. Sabir,. M.Si as Dean of the Faculty of Medicine, UNTAD
In addition to the signing ceremony of the cooperation agreement, Prodia and FK UNTAD also held a guest lecture session with the theme "Gut Microbiota in Cardiometabolic and Autoimmune Disease" by Dr. Rina Triana, M.Farm, Apt and dr. Ayu Sekarani DP, Sp.PD
This collaboration is part of Prodia's efforts to realize its vision as a Center of Excellence by supporting biomedical research for academic, epidemiological, and scientific publication purposes.
Prodia believes that synergy between industry and academia is crucial to strengthening the quality of healthcare services in the future.
#Prodia #HealthResearch #MedicalEducation #HealthcareInnovation #StrategicCollaboration #ClinicalLaboratory #HigherEducationPartnership #HealthierTogether
Related News



